|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Case report on an infant presenting with hypoglycemia,and milky serum显示文摘A 4-month-old male baby who presented in a moribund condition with seizures was found to have hepatomegaly,hypoglycemia and milky serum.Serum triglycerides were markedly elevated(3168 mg/dL) with cholesterol being 257 mg/dL and high density lipoprotein levels were low(19 mg/dL).The possibility of glycogen storage disease type Ⅰ was considered in the diagnosis.Infants with glycogen storage disease type Ⅰ may present like sepsis.The association of hepatomegaly, hypoglycemia and abnormal lipid profile stated above should alert the physician to consider glycogen storage disease type Ⅰ in the diagnosis. | Yogesh Kumar Gupta Anushre Prasad Pushpa Kini Prashant Naik Deepti Choprra Krishnananda Prabhu | 2012 | Asian Pacific Journal of Tropical Biomedicine2012，2，4： | 3 |
| 2 | 基于RAPD-PCR标记的印度亚麻品种遗传多样性和指纹图谱分析(英文)显示文摘栽培的亚麻(L.usitatissimum)通常为亚麻籽,以其油分和纤维而被认为是具有较高经济价值的作物之一。开发亚麻遗传资源并进一步进行遗传改良,须了解其遗传变异的范围和结构。位于坎普尔的C.S.农业科技大学种质管理单位保存有广泛收集而来的2772份栽培和野生亚麻资源。从中选出23份不同基因型栽培亚麻品种包括5份两用品种、4份种用品种、14份具有不同形态和经济特性的引进种用品种以及1份野生品系(L.grandiflorum),采用RAPD标记进行遗传多样性分析。20条随机引物共产生242条带,每条引物扩增带数为1~20条,平均为10.95条。所有基因型和位点的RAPD多态性比例为90.49%。DICE系数相似矩阵分析揭示其遗传相似性为0.63~0.97,平均相似系数为82%,说明这些亚麻品种(系)的遗传背景较窄。采用UPGMA法以及NTSYS-pc软件的SAHN聚类分析模型对遗传相似矩阵进行聚类分析,发现属于L.uitatisimums的所有栽培品种在X轴上可聚为一类,而L.grandiflorum野生种单独在Y轴上聚为一类。主成分分析结果表明,除了Shekha(r优良种用品种)和野生种L.grandiflorum广泛分布外,其他所有种用品种、两用品种和外来品种聚类很近。由于亚麻栽培品种的遗传关系相近,须对亚麻种质的各种基因型进行鉴定,以拓宽今后育种计划中的遗传基础。 | Prashant Shekhar Gupta Sangeeta Srivastava Manoj Kumar Srivastava Abhilash Gupta | 2010 | 广西农业科学2010，41，3： | 2 |
| 3 | Recombinant trehalose-6-phosphate phosphatase of Brugia malayi cross-reacts with human Wuchereria bancrofti immune sera and engenders a robust protective outcome in mice显示文摘 | Susheela Kushwaha Prashant Kumar Singh Jyoti Gupta Vishal Kumar Soni Shailja Misra-Bhattacharya | 2012 | Microbes and Infection2012，，14： | 1 |
| 4 | Glycemic Properties of Trichosanthes dioica Leaves显示文摘 | Prashant Kumar Rai Dolly Jaiswal Rakesh Kumar Singh Rajesh Kumar Gupta Geeta Watal | 2008 | Pharmaceutical Biology2008，，12： | 1 |
| 5 | Sex determination in 6 bovid species by duplex PCR显示文摘 | Prashant Gour D S Dubey P P Jain A Gupta S C Joshi B K Kumar D | 2008 | Journal of Applied Genetics2008，49，4： | 1 |
| 6 | Appraisal of land use/land cover of mangrove forest ecosystem using support vector machine显示文摘 | Sudhir Kumar Singh Prashant Srivastava Manika Gupta etc | 2014 | Environmental Earth Sciences2014，，5： | 1 |
| 7 | Ayurveda and in silico Approach: A Challenging Proficient Confluence for Better Development of Effective Traditional Medicine Spotlighting Network Pharmacology显示文摘Coalescence of traditional medicine Ayurveda and in silico technology is a rigor for supplementary development of future-ready effective traditional medicine. Ayurveda is a popular traditional medicine in South Asia, emanating worldwide for the treatment of metabolic disorders and chronic illness. Techniques of in silico biology are not much explored for the investigation of a variety of bioactive phytochemicals of Ayurvedic herbs. Drug repurposing, reverse pharmacology, and polypharmacology in Ayurveda are areas in silico explorations that are needed to understand the rich repertoire of herbs, minerals, herbo-minerals, and assorted Ayurvedic formulations. This review emphasizes exploring the concept of Ayurveda with in silico approaches and the need for Ayurinformatics studies. It also provides an overview of in silico studies done on phytoconstituents of some important Ayurvedic plants, the utility of in silico studies in Ayurvedic phytoconstituents/formulations, limitations/challenges, and prospects of in silico studies in Ayurveda. This article discusses the convergence of in silico work, especially in the least explored field of Ayurveda. The focused coalesce of these two domains could present a predictive combinatorial platform to enhance translational research magnitude. In nutshell, it could provide new insight into an Ayurvedic drug discovery involving an in silico approach that could not only alleviate the process of traditional medicine research but also enhance its effectiveness in addressing health care. | Rashmi Sahu Prashant Kumar Gupta Amit Mishra Awanish Kumar | 2023 | Chinese Journal of Integrative Medicine2023，29，5： | 0 |
| 8 | Promising Antiviral Molecules from Ayurvedic Herbs and Spices against COVID-19显示文摘COVID-19 is caused by the novel coronavirus severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)and smashed our society severely.Many efforts/measures have been taken worldwide to control coronavirus disease 2019(COVID-19)but it is spreading ceaselessly across the globe.Interestingly,Chinese medicine was used to treat COVID-19 and they found better recovery results.This has also drawn the attention of the scientific community to Ayurveda where traditional knowledge of this domain can be explored for finding COVID-19 a cure or prevention. | Mariappan Rajan Prashant Gupta Awanish Kumar | 2021 | Chinese Journal of Integrative Medicine2021，27，4： | 0 |
| 9 | Pharmacological, Ethnomedicinal, and Evidence-Based Comparative Review of Moringa oleifera Lam.(Shigru) and Its Potential Role in the Management of Malnutrition in Tribal Regions of India, Especially Chhattisgarh显示文摘Moringa oleifera Lam.(Shigru)(Moringaceae family) is a traditional medicine used for control of diabetes, obesity, asthma, and cardiac,liver, gastrointestinal, infective, and brain disorders, such as depression and Alzheimer's disease. In Ayurvedic literature, Shigru is among few drugs having Balya(nourishing) as well as Medohara(antiobesity) property. This review focuses on valid connections between the properties documented in ancient literature and current pharmacological knowledge of Moringa, including pharmacological actions, phytochemistry,botanical description, and how Moringa can tackle malnutrition in India, especially Chhattisgarh. All information about M. oleifera was obtained from electronic scientific databases such as PubMed, Web of Science, Scopus, ScienceDirect, Elsevier, Google Scholar, Traditional Knowledge Digital Library, and Indian Traditional Books(Ancient Ayurveda literatures, The Wealth of India, and The Ayurvedic Formulary of India), postgraduate/doctoral thesis, and googling the keyword M. oleifera. M. oleifera have anti-oxidant, antimicrobial, anti-diabetic,anti-obesity, anti-inflammatory, cardioprotective, hepatoprotective, neuroprotective, gastroprotective, wound-healing properties and it can potentially tackle malnutrition. This review describes the key information related to botanical description of M. oleifera, phytochemistry,pharmacological actions, clinical studies, toxicological studies, better utilization as food therapeutics, and ethnobotanical and evidence-based comparative review of M. oleifera. M. oleifera can effectively tackle malnutrition in India, especially Chhattisgarh. The authors emphasize the need for future in-depth ethnopharmacological lead-based research and clinical studies to expand M. oleifera pharmacological activities,clinical efficacy, and safety. | Kishor Sonewane Sharda Swaroop Chouhan Mariappan Rajan Nagendra Singh Chauhan Om Prakash Rout Awanish Kumar Gyanendra Singh Baghel Prashant Kumar Gupta | 2022 | World Journal of Traditional Chinese Medicine2022，8，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员